UPDATE 1-U.S. top court allows Apotex to pursue generic version of Daiichi drug

November 9, 2015 2:47 PM

2 0

WASHINGTON Nov 9 (Reuters) - The U.S. Supreme Court on Monday rejected appeals by Daiichi Sankyo Inc and Mylan Pharmaceuticals Inc seeking to stop Apotex Inc from trying to introduce a generic version of Benicar, a drug for treating hypertension.

The justices declined to review an April ruling by the U.S. Court of Appeals for the Federal Circuit in favor of Apotex.

Also read: EU Court Adviser Backs Intel Appeal Over $1.17 Billion Fine

Read more

To category page